- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07709481
Epilepsy Enhanced Care
Evaluating the Impact of Epilepsy Enhanced Care on Health Literacy in People With Epilepsy: A Nurse-led Educational Intervention Study
Background: Epilepsy is a common brain condition that causes repeated seizures. People with epilepsy often need a lot of information to manage their health, but many do not receive enough education about their condition. Having good health literacy (the ability to find, understand, and use health information) is important for managing epilepsy well.
Objective: This study aims to test whether a special educational program led by a trained epilepsy nurse, called "Epilepsy Enhanced Care," helps adults with epilepsy better understand and manage their health.
Study design: This is a prospective, non-randomized, controlled study involving adults (aged 18 years or older) with epilepsy. Participants will be divided into three groups:
- Intervention group: Patients with newly diagnosed epilepsy who will receive the "Epilepsy Enhanced Care" educational program in addition to their usual care.
- Control group 1: Patients with newly diagnosed epilepsy who will receive only their usual care.
- Control group 2: Patients who have had epilepsy for at least one year and will receive only their usual care.
Intervention: The "Epilepsy Enhanced Care" program is a structured, one-on-one educational session delivered by a specialized epilepsy nurse within 2 months of diagnosis. The session covers topics such as epilepsy types, medications, safety planning, and lifestyle management. Patients and their caregivers may attend together. After the session, participants can contact the nurse by phone or email with further questions.
Outcomes: The main outcome is the change in health literacy from the start of the study to 3 months after the intervention. Secondary outcomes include changes in epilepsy-specific knowledge, self-management skills, quality of life, anxiety, depression symptoms, and how often patients use healthcare services.
Study duration: Participants in the intervention group and control group 1 will be followed for 12 months. Participants in control group 2 will be assessed at a single time point. The entire study is expected to take 24 months.
Risks and benefits: The intervention involves only education and counseling, with no medications or medical devices. The risks are minimal, and participation is voluntary.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Age ≥18 years;
- Confirmed epilepsy diagnosis (ILAE criteria);
- Ability to provide informed consent (or legal representative);
- Sufficient Italian proficiency.
Exclusion Criteria:
- Previous participation in a structured epilepsy education program;
- Severe untreated comorbidities precluding attendance.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Outro
- Alocação: Não randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Index group (newly diagnosed epilepsy + intervention)
Epilepsy Enhanced Care
|
A structured, nurse-led educational program delivered by a specialized epilepsy nurse.
Includes a comprehensive consultation (within 2 months after diagnosis) covering epilepsy types, anti-seizure medications, safety planning, lifestyle management.
Caregivers encouraged to attend.
Follow-up access via telephone/email.
|
|
Sem intervenção: Control group 1 (newly diagnosed epilepsy, standard care only)
|
|
|
Sem intervenção: Control group 2 (established epilepsy, standard care only, cross-sectional)
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Improvement in health literacy
Prazo: From baseline to 3 months after enrollment
|
Measured using Domain 2 ("Having sufficient information to manage my health") of the Health Literacy Questionnaire (HLQ).
|
From baseline to 3 months after enrollment
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Changes in scores on other seven domains of the HLQ
Prazo: From baseline to 3 and 12 months after enrollment
|
For each endpoint, the change in score from baseline to follow-up will be measured in the intervention groups, and scores will be compared between the intervention and control groups at follow-up
|
From baseline to 3 and 12 months after enrollment
|
|
Change in Epilepsy-specific knowledge score
Prazo: From baseline to 3 and 12 months after enrollment
|
From baseline to 3 and 12 months after enrollment
|
|
|
Change in Epilepsy Self-Management score
Prazo: From baseline to 3 and 12 months after enrollment
|
From baseline to 3 and 12 months after enrollment
|
|
|
Change in Generalized Anxiety Disorder 7 score
Prazo: From baseline to 3 and 12 months after enrollment
|
From baseline to 3 and 12 months after enrollment
|
|
|
Change in Neurological Disorders Depression Inventory for Epilepsy score
Prazo: From baseline to 3 and 12 months after enrollment
|
From baseline to 3 and 12 months after enrollment
|
|
|
Healthcare utilization
Prazo: From baseline to 3 and 12 months after enrollment
|
Frequency of epilepsy-related emergency department visits, epilepsy-related hospitalizations, and unscheduled neurology consultations, collected through patient self-report and, where available, verified through electronic medical records.
|
From baseline to 3 and 12 months after enrollment
|
Outras medidas de resultado
Medida de resultado |
Prazo |
|---|---|
|
Patient satisfaction score
Prazo: At 3 months after enrollment
|
At 3 months after enrollment
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- CE5171
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Epilepsy Enhanced Care
-
University of Alabama at BirminghamUS Department of Veterans Affairs; University of California, San Francisco; University...ConcluídoDoença de obstrução pulmonar crônica | Insuficiência Cardíaca CongestivaEstados Unidos
-
Istanbul Sabahattin Zaim UniversityConcluídoEpilepsia | Terapia medicamentosa | Estigma | Auto GerenciamentoPeru
-
University of HaifaConcluídoPaternidade | Problema de comportamento infantil | Engajamento, PacienteIsrael
-
David Grant U.S. Air Force Medical CenterConcluído
-
VA Office of Research and DevelopmentIcahn School of Medicine at Mount Sinai; Weill Medical College of Cornell University e outros colaboradoresConcluídoToxicidade de MedicamentosEstados Unidos
-
InSightecConcluídoMiomas uterinos | Leiomioma uterinoEstados Unidos, Canadá
-
Arizona Heart InstituteDesconhecidoAneurisma da aorta abdominalEstados Unidos
-
Kocaeli Derince Education and Research HospitalKocaeli UniversityDesconhecidoRecuperação aprimorada após a cirurgia | Cirurgia de Coração AbertoPeru
-
King's College Hospital NHS TrustAtivo, não recrutando
-
Cairo UniversityAinda não está recrutandoDesarranjo Interno da Articulação Temporomandibular